The Drug Recognition Guide, 2nd Edition

 

Description:

The Drug Recognition Guide introduces an innovative method for recognising and categorising medications, enabling readers to easily identify the type and use of a generic drug by visually deconstructing its name.

Through its creative use of colour-coded drug prefixes and suffixes, this pocket-sized guide makes generic drug names distinctive, logical, and easy to pronounce and remember.

 More than 700 drugs from over 200 different drug categories are catalogued and colour-highlighted--helping you understand what underlies a generic drug name.

 

Organised by class and use, the book’s ten chapters cover a comprehensive range of drugs, including chemotherapy and immunosuppressants, drugs that affect the cardiovascular and respiratory systems, drugs used to manage pain, treat infectious diseases, and many others.

 Each entry briefly summarises a particular class of drugs, describes the intended use of drugs within the class, and breaks down the “name stems” of individual drugs to reveal useful information and illustrate connections between chemically and therapeutically related medicines.

  

Presenting an original, easy-to-use approach to the complex subject of drug classification, this invaluable learning aid: 

Provides a thorough yet accessible way for students and practitioners to increase their understanding of medications and their application 

Helps students to clearly read and pronounce even the most difficult generic drug names 

Highlights the letters in generic drug names to enable students to recognise drugs immediately 

Explains who assigns a generic drug name and what the name represents 

Includes an introduction to generic and proprietary drug names and design motifs 

The Drug Recognition Guide is essential reading for nursing and medical students, pharmacy students and technicians, as well as nurse practitioners and trainee and junior doctors.

 

 

 

 

 

 

Table of Contents:

 

 

 

Drug names: generic/proprietary

 

Comparison of rINNs in English, French, Spanish, Portuguese and Italian

Drug names and design motifs

Information about the guide

References

1 Drugs that affect the gastrointestinal system

Aminosalicylates

Antispasmodics

Antimuscarinic antispasmodics

Direct‐acting smooth muscle relaxants

H2‐receptor antagonists

Laxatives

Proton pump inhibitors (PPIs)

References

2 Drugs that affect the cardiovascular system

ACE inhibitors

Alpha‐1 adrenoceptor blockers

Angiotensin receptor blockers

Beta‐blockers

Calcium channel blockers

Class I calcium channel blockers

Class II calcium channel blockers

Class III calcium channel blockers

Centrally‐acting antihypertensives

Diuretics

Loop diuretics

Thiazide diuretics

Potassium‐sparing diuretics and aldosterone antagonists

Osmotic diuretics

Endothelin receptor antagonists

Potassium channel activators

Renin inhibitors

Antiarrhythmics

Class I antiarrhythmics

Class II antiarrhythmics

Class III antiarrhythmics

Class IV antiarrhythmics

Class V antiarrhythmics

Cardiac glycosides

Nitrates

References

3 Drugs that affect blood coagulation and lipids

Anticoagulants

Direct factor Xa inhibitors

Direct thrombin inhibitors

Heparins

Heparinoids

Hirudin analogues

Prostaglandin analogues

Synthetic pentasaccharides

Vitamin K antagonists

Antiplatelets

Cyclo‐oxygenase (COX) inhibitors

Glycoprotein IIb and IIIa inhibitors

P2Y12 platelet receptor antagonists

Phosphodiesterase inhibitors

Fibrinolytics

Lipid‐regulating agents

Bile acid sequestrants

Cholesterol absorption inhibitors

Fibrates

Miscellaneous lipid‐regulating agents

MTP inhibitors

PCSK9 inhibitors

Statins (HMG CoA reductase inhibitors)

References

4 Drugs that affect the respiratory system

Respiratory disease drugs

Antimuscarinics

Beta‐2 agonists

Corticosteroids

Leukotriene receptor antagonists

Monoclonal antibodies

Phosphodiesterase type‐4 inhibitors

Xanthines

References

5 Drugs that affect the central and peripheral nervous system

Antiepileptic drugs

Antidepressants

Monoamine oxidase inhibitors (MAOIs)

Serotonin and/or noradrenaline reuptake inhibitors (SSRI, NRI, SNRI and SMS)

Tricyclic antidepressants (TCAs)

Miscellaneous antidepressants

Antipsychotics

First‐generation antipsychotics

Second‐generation antipsychotics

Second‐generation antipsychotics

Benzodiazepines

Non‐benzodiazepine sedatives

Cyclopyrrolones and imidazopyridines

Melatonin receptor agonists

Antihistamines

Antimuscarinics

Parkinson's disease drugs

Levodopa and DDI compounds

COMT inhibitors

Dopamine receptor agonists

Monoamine oxidase‐B inhibitors

Antimuscarinic antiparkinsonian drugs

Glutamate antagonists

References

6 Drugs used in the management of pain

Analgesics

Non‐opioid analgesics

Compound analgesics

Opioid analgesics

5HT‐1 agonists

Non‐steroidal anti‐inflammatory drugs (NSAIDs)

Enolic acid class NSAIDs

Acetic acid, propionic acid and fenamic acid class NSAIDs

Cyclo‐oxygenase (COX)‐2 inhibitors

References

7 Antiemetics: drugs used in the management of nausea and vomiting

Antiemetics

Analogues of histamine

Antihistamine antiemetics

Antimuscarinic antiemetics

Dopamine receptor antagonists

5HT‐3 receptor antagonists

Neurokinin‐1 receptor antagonists

Phenothiazines

References

8 Diabetes drug therapy and other medicines that affect the endocrine system

Insulins

Short‐acting insulins

Intermediate and long‐acting insulins

Biphasic insulins

Antidiabetic drugs

Alpha‐glucosidase inhibitors

Biguanides

Dipeptidylpeptidase‐4 inhibitors

Glucagon‐like peptide‐1 agonists

Meglitinides

Sodium‐glucose (linked) co‐transporter 2 inhibitors

Sulfonylureas

Thiazolidinediones

Bisphosphonates

Corticosteroids

Phosphodiesterase inhibitors

Prostaglandin analogues

References

9 Antimicrobials: drugs used to treat infectious diseases

Antibacterials

Aminoglycosides

Carbapenems

Cephalosporins

Compound antibiotics

Folic acid inhibitors

Lincosamides

Lipopeptides and glycopeptides

Macrocyclic antibiotics

Macrolides

Nitrofuran derivatives

Nitroimidazoles

Oxazolidinones

Penicillins

Quinolones

Rifamycins

Sulfonamides

Tetracyclines and glycylcyclines

Antifungals

Antivirals

Antiretrovirals

References

10 Chemotherapy and immunomodulatingagents

Chemotherapy

Alkylating agents

Antimetabolites

Cytotoxic antibiotics

Platinum compounds

Proteasome inhibitors

Protein (and tyrosine) kinase inhibitors

Taxanes

Topoisomerase‐inhibiting agents

Vinca alkaloids

Sex hormones and hormone antagonists

Immunomodulating agents

Analogues of thalidomide

Antiproliferative immunosuppressants

Calcineurin and ‘non‐calcineurin’ inhibiting immunosuppressants

Monoclonal antibodies

References

Index

Index

End User License Agreement